Acarix (private company)

See something wrong or missing? Let us know
Offices:Copenhagen
Business model:B2B

Acarix A/S is based on pioneering research performed at the Aalborg University, Denmark, initiated in 2004. The research group received the award, ‘MedicoPrisen’, from Medicoindustrien (Danish Medtech trade association) in 2007.

A research and development collaboration was established in 2007 between Aalborg University and Coloplast A/S, receiving public support from the Danish National Advanced Technology Foundation in 2008.

Acarix A/S was established in 2009 as a spin-out company from Coloplast A/S with Coloplast A/S and Aalborg University as the major shareholders.

In 2010 Acarix A/S succeeded attracting venture capital from Seed Capital (DK), Sunstone Capital (DK) and Seventure Partners (F).

In 2011 Acarix A/S and collaborators furthermore achieved funding of 5.3 million DKK from the Danish Business Innovation Fund.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 11.81M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Acarix

Name Criteria
Denmark CathVision
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Innovationsfonden
  • Total raised in a similar range: 10M+ USD
Netherlands Citryll
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Seventure Partners
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Denmark Galecto Biotech
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Seed Capital, Seventure Partners, Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
France MaaT Pharma
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Seventure Partners
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Seed Capital, Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Switzerland Synendos Therapeutics
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Germany Tubulis
50%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Seventure Partners
  • Total raised in a similar range: 10M+ USD
Denmark Absolute Liquid Solutions
40%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Seed Capital

News about Acarix


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Top